Mukesh M Agarwal1, Gurdeep S Dhatt, Yusra Othman. 1. Department of Pathology, Faculty of Medicine, UAE University, P.O. Box 17666, Al Ain, United Arab Emirates. magarwal7@gmail.com
Abstract
BACKGROUND: The American Diabetes Association has endorsed the International Association of Diabetes and Pregnancy Groups (IADPSG) recommendation that every pregnant woman should undergo the 75 g oral glucose tolerance test (OGTT) to screen for gestational diabetes mellitus (GDM). PURPOSE: To find the cost and workload implications of switching from the current two-step screening of GDM to the one-step IADPSG approach. METHODS: The cost (US $) and laboratory workload units (WLU) were calculated for three possible strategies: (1) 50 g glucose screen, if positive, followed by the 100 g OGTT; (2) universal 75 g OGTT; and (3) screening with the initial fasting plasma glucose of the OGTT. RESULTS: For the 1,101 pregnant women screened in 1 year, the cost of the three strategies was $ 31,985, $ 55,250 and $ 35,875, respectively; the laboratory burden was 28,975 WLU, 18,662 WLU and 12,215 WLU, respectively. CONCLUSIONS: Switching to the one-step, strategy 2 (IADPSG) would increase the cost by 42 % but decrease the laboratory workload by 36 % compared to the two-step, strategy 1. However, an initial screen by the fasting plasma glucose of the OGTT is the ideal strategy, both in terms of cost and laboratory workload.
BACKGROUND: The American Diabetes Association has endorsed the International Association of Diabetes and Pregnancy Groups (IADPSG) recommendation that every pregnant woman should undergo the 75 g oral glucose tolerance test (OGTT) to screen for gestational diabetes mellitus (GDM). PURPOSE: To find the cost and workload implications of switching from the current two-step screening of GDM to the one-step IADPSG approach. METHODS: The cost (US $) and laboratory workload units (WLU) were calculated for three possible strategies: (1) 50 g glucose screen, if positive, followed by the 100 g OGTT; (2) universal 75 g OGTT; and (3) screening with the initial fasting plasma glucose of the OGTT. RESULTS: For the 1,101 pregnant women screened in 1 year, the cost of the three strategies was $ 31,985, $ 55,250 and $ 35,875, respectively; the laboratory burden was 28,975 WLU, 18,662 WLU and 12,215 WLU, respectively. CONCLUSIONS: Switching to the one-step, strategy 2 (IADPSG) would increase the cost by 42 % but decrease the laboratory workload by 36 % compared to the two-step, strategy 1. However, an initial screen by the fasting plasma glucose of the OGTT is the ideal strategy, both in terms of cost and laboratory workload.
Authors: Min Hyoung Kim; Soo Heon Kwak; Sung Hoon Kim; Joon Seok Hong; Hye Rim Chung; Sung Hee Choi; Moon Young Kim; Hak C Jang Journal: Diabetes Metab J Date: 2019-02-28 Impact factor: 5.376
Authors: Joseph Mussa; Sara Meltzer; Rachel Bond; Natasha Garfield; Kaberi Dasgupta Journal: Int J Environ Res Public Health Date: 2021-02-04 Impact factor: 3.390